世界の肺がん用リキッドバイオプシー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lung Cancer Liquid Biopsy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3492 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、肺がん用リキッドバイオプシーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CTC、CtDNA、エクソソーム・RNA、その他）、用途別市場規模（クリニック、病院、医師オフィス研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肺がん用リキッドバイオプシーの市場動向 ・企業の競争状況、市場シェア ・肺がん用リキッドバイオプシーの種類別市場規模（CTC、CtDNA、エクソソーム・RNA、その他） ・肺がん用リキッドバイオプシーの用途別市場規模（クリニック、病院、医師オフィス研究所） ・肺がん用リキッドバイオプシーの北米市場規模2016-2027（アメリカ、カナダ） ・肺がん用リキッドバイオプシーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺がん用リキッドバイオプシーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺がん用リキッドバイオプシーの中南米市場規模2016-2027（メキシコ、ブラジル） ・肺がん用リキッドバイオプシーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biocept、Exosome Diagnostics、F. Hoffmann-La Roche、Qiagen、Accuragen、Agena Bioscience、Bard1、Bgi） ・結論

Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.
CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.

Market Analysis and Insights: Global Lung Cancer Liquid Biopsy Market
The global Lung Cancer Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Liquid Biopsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Liquid Biopsy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Liquid Biopsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Liquid Biopsy market.

Global Lung Cancer Liquid Biopsy Scope and Market Size
Lung Cancer Liquid Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CTCs
CtDNA
Exosomes And RNA
Others

Segment by Application
Clinics
Hospitals
Physicians’ Office Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biocept
Exosome Diagnostics
F. Hoffmann-La Roche
Qiagen
Accuragen
Agena Bioscience
Bard1
Bgi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CTCs
1.2.3 CtDNA
1.2.4 Exosomes And RNA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lung Cancer Liquid Biopsy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Physicians’ Office Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Liquid Biopsy Market Perspective (2016-2027)
2.2 Lung Cancer Liquid Biopsy Growth Trends by Regions
2.2.1 Lung Cancer Liquid Biopsy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Liquid Biopsy Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Liquid Biopsy Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Liquid Biopsy Industry Dynamic
2.3.1 Lung Cancer Liquid Biopsy Market Trends
2.3.2 Lung Cancer Liquid Biopsy Market Drivers
2.3.3 Lung Cancer Liquid Biopsy Market Challenges
2.3.4 Lung Cancer Liquid Biopsy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue
3.1.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Liquid Biopsy Revenue
3.4 Global Lung Cancer Liquid Biopsy Market Concentration Ratio
3.4.1 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biopsy Revenue in 2020
3.5 Lung Cancer Liquid Biopsy Key Players Head office and Area Served
3.6 Key Players Lung Cancer Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Lung Cancer Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Liquid Biopsy Breakdown Data by Type
4.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Liquid Biopsy Breakdown Data by Application
5.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lung Cancer Liquid Biopsy Market Size (2016-2027)
6.2 North America Lung Cancer Liquid Biopsy Market Size by Type
6.2.1 North America Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
6.3 North America Lung Cancer Liquid Biopsy Market Size by Application
6.3.1 North America Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
6.4 North America Lung Cancer Liquid Biopsy Market Size by Country
6.4.1 North America Lung Cancer Liquid Biopsy Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Liquid Biopsy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Lung Cancer Liquid Biopsy Market Size (2016-2027)
7.2 Europe Lung Cancer Liquid Biopsy Market Size by Type
7.2.1 Europe Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Liquid Biopsy Market Size by Application
7.3.1 Europe Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Liquid Biopsy Market Size by Country
7.4.1 Europe Lung Cancer Liquid Biopsy Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Liquid Biopsy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lung Cancer Liquid Biopsy Market Size (2016-2027)
9.2 Latin America Lung Cancer Liquid Biopsy Market Size by Type
9.2.1 Latin America Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Liquid Biopsy Market Size by Application
9.3.1 Latin America Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Liquid Biopsy Market Size by Country
9.4.1 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Details
11.1.2 Biocept Business Overview
11.1.3 Biocept Lung Cancer Liquid Biopsy Introduction
11.1.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.1.5 Biocept Recent Development
11.2 Exosome Diagnostics
11.2.1 Exosome Diagnostics Company Details
11.2.2 Exosome Diagnostics Business Overview
11.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Introduction
11.2.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.2.5 Exosome Diagnostics Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Lung Cancer Liquid Biopsy Introduction
11.4.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.4.5 Qiagen Recent Development
11.5 Accuragen
11.5.1 Accuragen Company Details
11.5.2 Accuragen Business Overview
11.5.3 Accuragen Lung Cancer Liquid Biopsy Introduction
11.5.4 Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.5.5 Accuragen Recent Development
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Details
11.6.2 Agena Bioscience Business Overview
11.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Introduction
11.6.4 Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.6.5 Agena Bioscience Recent Development
11.7 Bard1
11.7.1 Bard1 Company Details
11.7.2 Bard1 Business Overview
11.7.3 Bard1 Lung Cancer Liquid Biopsy Introduction
11.7.4 Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.7.5 Bard1 Recent Development
11.8 Bgi
11.8.1 Bgi Company Details
11.8.2 Bgi Business Overview
11.8.3 Bgi Lung Cancer Liquid Biopsy Introduction
11.8.4 Bgi Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.8.5 Bgi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CTCs
Table 3. Key Players of CtDNA
Table 4. Key Players of Exosomes And RNA
Table 5. Key Players of Others
Table 6. Global Lung Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lung Cancer Liquid Biopsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lung Cancer Liquid Biopsy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Lung Cancer Liquid Biopsy Market Share by Regions (2016-2021)
Table 10. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Lung Cancer Liquid Biopsy Market Share by Regions (2022-2027)
Table 12. Lung Cancer Liquid Biopsy Market Trends
Table 13. Lung Cancer Liquid Biopsy Market Drivers
Table 14. Lung Cancer Liquid Biopsy Market Challenges
Table 15. Lung Cancer Liquid Biopsy Market Restraints
Table 16. Global Lung Cancer Liquid Biopsy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Lung Cancer Liquid Biopsy Market Share by Players (2016-2021)
Table 18. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biopsy as of 2020)
Table 19. Ranking of Global Top Lung Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Lung Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lung Cancer Liquid Biopsy Product Solution and Service
Table 23. Date of Enter into Lung Cancer Liquid Biopsy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2016-2021)
Table 27. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Lung Cancer Liquid Biopsy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2016-2021)
Table 31. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Lung Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Lung Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Lung Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Lung Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Biocept Company Details
Table 64. Biocept Business Overview
Table 65. Biocept Lung Cancer Liquid Biopsy Product
Table 66. Biocept Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 67. Biocept Recent Development
Table 68. Exosome Diagnostics Company Details
Table 69. Exosome Diagnostics Business Overview
Table 70. Exosome Diagnostics Lung Cancer Liquid Biopsy Product
Table 71. Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 72. Exosome Diagnostics Recent Development
Table 73. F. Hoffmann-La Roche Company Details
Table 74. F. Hoffmann-La Roche Business Overview
Table 75. F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Product
Table 76. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 77. F. Hoffmann-La Roche Recent Development
Table 78. Qiagen Company Details
Table 79. Qiagen Business Overview
Table 80. Qiagen Lung Cancer Liquid Biopsy Product
Table 81. Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 82. Qiagen Recent Development
Table 83. Accuragen Company Details
Table 84. Accuragen Business Overview
Table 85. Accuragen Lung Cancer Liquid Biopsy Product
Table 86. Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 87. Accuragen Recent Development
Table 88. Agena Bioscience Company Details
Table 89. Agena Bioscience Business Overview
Table 90. Agena Bioscience Lung Cancer Liquid Biopsy Product
Table 91. Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 92. Agena Bioscience Recent Development
Table 93. Bard1 Company Details
Table 94. Bard1 Business Overview
Table 95. Bard1 Lung Cancer Liquid Biopsy Product
Table 96. Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 97. Bard1 Recent Development
Table 98. Bgi Company Details
Table 99. Bgi Business Overview
Table 100. Bgi Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 101. Bgi Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Liquid Biopsy Market Share by Type: 2020 VS 2027
Figure 2. CTCs Features
Figure 3. CtDNA Features
Figure 4. Exosomes And RNA Features
Figure 5. Others Features
Figure 6. Global Lung Cancer Liquid Biopsy Market Share by Application: 2020 VS 2027
Figure 7. Clinics Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Physicians' Office Laboratories Case Studies
Figure 10. Lung Cancer Liquid Biopsy Report Years Considered
Figure 11. Global Lung Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Lung Cancer Liquid Biopsy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lung Cancer Liquid Biopsy Market Share by Regions: 2020 VS 2027
Figure 14. Global Lung Cancer Liquid Biopsy Market Share by Regions (2022-2027)
Figure 15. Global Lung Cancer Liquid Biopsy Market Share by Players in 2020
Figure 16. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biopsy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biopsy Revenue in 2020
Figure 18. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2016-2021)
Figure 19. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2022-2027)
Figure 20. North America Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 22. North America Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 23. North America Lung Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 24. United States Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 28. Europe Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 29. Europe Lung Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 30. Germany Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Lung Cancer Liquid Biopsy Market Share by Region (2016-2027)
Figure 40. China Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 48. Latin America Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 49. Latin America Lung Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 50. Mexico Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Lung Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 56. Turkey Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Biocept Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 60. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 62. Qiagen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 63. Accuragen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 64. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 65. Bard1 Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 66. Bgi Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---